FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079716843> ?p ?o ?g. }

• W2079716843 endingPage "80" @default.
• W2079716843 startingPage "73" @default.
• W2079716843 abstract "Background: Combination diphtheria-tetanus-5 component acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine (DTaP5-IPV-Hib-HepB) administered either concurrently with 7-valent pneumococcal conjugate vaccine (PCV7) or 1 month apart was generally safe and immunogenic at 2, 4 and 6 months of age. This study examined the effects of a booster dose at age 15 months. Methods: Participants were randomized to DTaP5-IPV-Hib-HepB plus PCV7, DTaP5-IPV-Hib-HepB with PCV7 administered 1 month later or a pentavalent DTaP5-IPV/Hib plus HepB plus PCV7 at 15 months of age in a randomized, open-label, phase IIb clinical trial. Immunogenicity endpoints were rates of seroresponse to pertussis toxoid, filamentous hemagglutinin, pertactin and fimbriae types 2 and 3; rates of seroprotection against (Hib) polyribosylribitol phosphate capsular polysaccharide, hepatitis B surface antigen, diphtheria toxoid, tetanus toxoid and poliovirus types 1, 2 and 3; and geometric mean titers to all vaccine antigens. Safety endpoints included solicited injection-site reactions and systemic and serious adverse events. Results: Seroresponse/seroprotection rates for all antigens exceeded prespecified criteria in both groups that received the hexavalent DTaP5-IPV-Hib-HepB; in the group that received the currently licensed pentavalent vaccine, seroresponse/seroprotection rates exceeded the criteria for all antigens except filamentous hemagglutinin. Seroresponse rates were ≥88.9% for pertussis antigens and seroprotection rates against polyribosylribitol phosphate capsular polysaccharide, hepatitis B surface antigen, diphtheria toxoid, tetanus toxoid and poliovirus antigens were ≥95.1% in recipients of DTaP5-IPV-Hib-HepB. Conclusions: DTaP5-IPV-Hib-HepB administered concomitantly with PCV7 or 1 month apart at 15 months of age following the infant series was well-tolerated and elicited antibody responses to all vaccine antigens, with no significant interference from concomitant PCV7 administration (clinicaltrials.gov registration number NCT00362427)." @default.
• W2079716843 created "2016-06-24" @default.
• W2079716843 creator A5017186738 @default.
• W2079716843 creator A5028428160 @default.
• W2079716843 creator A5044817724 @default.
• W2079716843 creator A5045040015 @default.
• W2079716843 creator A5060948315 @default.
• W2079716843 creator A5066891238 @default.
• W2079716843 creator A5070330715 @default.
• W2079716843 creator A5075513872 @default.
• W2079716843 creator A5079876623 @default.
• W2079716843 creator A5082989514 @default.
• W2079716843 creator A5083852765 @default.
• W2079716843 creator A5085353724 @default.
• W2079716843 date "2014-01-01" @default.
• W2079716843 modified "2023-10-11" @default.
• W2079716843 title "Safety and Immunogenicity of a Toddler Dose Following an Infant Series of a Hexavalent Diphtheria, Tetanus, Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae Type b, Hepatitis B Vaccine Administered Concurrently or at Separate Visits With a Heptavalent Pneumococcal Conjugate Vaccine" @default.
• W2079716843 cites W1975697972 @default.
• W2079716843 cites W1979841030 @default.
• W2079716843 cites W1981573468 @default.
• W2079716843 cites W2004239384 @default.
• W2079716843 cites W2010942366 @default.
• W2079716843 cites W2012859758 @default.
• W2079716843 cites W2020569330 @default.
• W2079716843 cites W2040556080 @default.
• W2079716843 cites W2051998861 @default.
• W2079716843 cites W2054816006 @default.
• W2079716843 cites W2054922301 @default.
• W2079716843 cites W2058867673 @default.
• W2079716843 cites W2060463456 @default.
• W2079716843 cites W2086311575 @default.
• W2079716843 cites W2090499893 @default.
• W2079716843 cites W2092145494 @default.
• W2079716843 doi "https://doi.org/10.1097/01.inf.0000437806.76221.20" @default.
• W2079716843 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24346596" @default.
• W2079716843 hasPublicationYear "2014" @default.
• W2079716843 type Work @default.
• W2079716843 sameAs 2079716843 @default.
• W2079716843 citedByCount "21" @default.
• W2079716843 countsByYear W20797168432014 @default.
• W2079716843 countsByYear W20797168432015 @default.
• W2079716843 countsByYear W20797168432016 @default.
• W2079716843 countsByYear W20797168432017 @default.
• W2079716843 countsByYear W20797168432018 @default.
• W2079716843 countsByYear W20797168432019 @default.
• W2079716843 countsByYear W20797168432020 @default.
• W2079716843 countsByYear W20797168432021 @default.
• W2079716843 countsByYear W20797168432023 @default.
• W2079716843 crossrefType "journal-article" @default.
• W2079716843 hasAuthorship W2079716843A5017186738 @default.
• W2079716843 hasAuthorship W2079716843A5028428160 @default.
• W2079716843 hasAuthorship W2079716843A5044817724 @default.
• W2079716843 hasAuthorship W2079716843A5045040015 @default.
• W2079716843 hasAuthorship W2079716843A5060948315 @default.
• W2079716843 hasAuthorship W2079716843A5066891238 @default.
• W2079716843 hasAuthorship W2079716843A5070330715 @default.
• W2079716843 hasAuthorship W2079716843A5075513872 @default.
• W2079716843 hasAuthorship W2079716843A5079876623 @default.
• W2079716843 hasAuthorship W2079716843A5082989514 @default.
• W2079716843 hasAuthorship W2079716843A5083852765 @default.
• W2079716843 hasAuthorship W2079716843A5085353724 @default.
• W2079716843 hasBestOaLocation W20797168431 @default.
• W2079716843 hasConcept C126322002 @default.
• W2079716843 hasConcept C147483822 @default.
• W2079716843 hasConcept C159047783 @default.
• W2079716843 hasConcept C170493617 @default.
• W2079716843 hasConcept C196419574 @default.
• W2079716843 hasConcept C203014093 @default.
• W2079716843 hasConcept C22070199 @default.
• W2079716843 hasConcept C2522874641 @default.
• W2079716843 hasConcept C2777351567 @default.
• W2079716843 hasConcept C2779583294 @default.
• W2079716843 hasConcept C2779592421 @default.
• W2079716843 hasConcept C2779631682 @default.
• W2079716843 hasConcept C2779841045 @default.
• W2079716843 hasConcept C2780572238 @default.
• W2079716843 hasConcept C2780868878 @default.
• W2079716843 hasConcept C2908689829 @default.
• W2079716843 hasConcept C49773422 @default.
• W2079716843 hasConcept C71924100 @default.
• W2079716843 hasConcept C80631254 @default.
• W2079716843 hasConcept C8439097 @default.
• W2079716843 hasConceptScore W2079716843C126322002 @default.
• W2079716843 hasConceptScore W2079716843C147483822 @default.
• W2079716843 hasConceptScore W2079716843C159047783 @default.
• W2079716843 hasConceptScore W2079716843C170493617 @default.
• W2079716843 hasConceptScore W2079716843C196419574 @default.
• W2079716843 hasConceptScore W2079716843C203014093 @default.
• W2079716843 hasConceptScore W2079716843C22070199 @default.
• W2079716843 hasConceptScore W2079716843C2522874641 @default.
• W2079716843 hasConceptScore W2079716843C2777351567 @default.
• W2079716843 hasConceptScore W2079716843C2779583294 @default.
• W2079716843 hasConceptScore W2079716843C2779592421 @default.
• W2079716843 hasConceptScore W2079716843C2779631682 @default.
• W2079716843 hasConceptScore W2079716843C2779841045 @default.
• W2079716843 hasConceptScore W2079716843C2780572238 @default.
• W2079716843 hasConceptScore W2079716843C2780868878 @default.
• W2079716843 hasConceptScore W2079716843C2908689829 @default.

• next